The investigational antifungal agent olorofim showed efficacy in 29% of patients with invasive fungal disease who had few or no treatment options. A successful global response with stable disease ...

A new class of antifungals has been identified, potentially useful to treat the more than 300 million people worldwide who develop serious fungal infections. Fungal infections are most commonly found ...

A recent study published in the journal Biomedicines aimed to determine the antifungal tolerance of Candida auris (C. auris) to all three classes of antifungal drugs commonly used to treat invasive ...

Scientists have uncovered an unexpected potential treatment for persistent nail infections, using a gas best known for its foul smell.

The pharmacology, bioavailability and pharmacokinetics, clinical efficacy, and adverse effects of caspofungin acetate are reviewed. Caspofungin acetate is an echinocandin with fungicidal activity ...

Unusual components from carnivorous plants' pitchers were found effective as anti-fungal drugs against human fungal infections, which are widespread in hospitals. In the tropics, carnivorous plants ...

Sigma-Aldrich CorporationSIAL declared that the Cerilliant brand under its Applied Diagnostics and Testing business unit has launched five new stable-labeled internal standards of the antifungal ...

Despite advances in preventive, diagnostic, and therapeutic interventions, invasive fungal infections cause significant morbidity and mortality in immunocompromised patients. The burden of antifungal ...

In a recent study published in the journal Molecular Therapy, researchers identified Bifonazole, an imidazole-based antifungal agent, to have potent activity against severe acute respiratory syndrome ...

(RTTNews) - Sandoz said it has entered into an agreement to acquire worldwide product rights for systemic antifungal agent Mycamine from Astellas Pharma Inc. (ALPMY, ALPMY). Closing is anticipated in ...